Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Research and Markets: The Outlook for Pharmaceuticals in Latin America. Strong Pharmaceutical Market Growth Opportunities and Regulatory Developments Are Making Latin America More Attractive

Research and Markets
Posted on: 16 Mar 12

Research and Markets ( has announced the addition of the "The Outlook for Pharmaceuticals in Latin America" report to their offering.

The region needs to increase drug access, in spite of intensifying cost-containment measures. Therefore, attractive opportunities for (bio)pharmaceutical producers exist in Latin America. Brazil has the largest pharmaceutical market. Strong economic performance will fuel pharmacy sales growth in the forecast period. Mexico is the second leading market. Recent regulatory developments will create further market opportunities in the country, particularly for generic producers in both the private and public sectors. In Argentina, the pharmaceutical industry is expected to perform well in the coming years, with strong growth in production, sales, exports and employment. Pharmaceutical companies, however, are encouraged to act in smaller Latin American markets to maximise their full regional sales potential.

Generics consumption in Latin America is low, with the exception of Brazil which has a dynamic bioequivalent generic sector. In the last two years, foreign producers have penetrated what, until then, had been considered a tough sector due to local protectionism and low prices.

These Reports Analyse the Issues:

The Outlook for Pharmaceuticals in Latin America is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, together with a comprehensive statistical appendix. There are over 60 markets covered in the worldwide series.

Key Topics Covered:


  • Current market size
  • Unique 5-Year market projections to 2012
  • Market outlook
  • Comment & rating, covering 8 key areas such as use of generic drugs, intellectual property, pricing and the health systems
  • Market structure
  • Statistical data on imports and exports
  • Market developments, covering recent and impending developments with respect to key issues such as regulation, health facilities, funding and government policy
  • Key national data projections

BACKGROUND DATA Population data, including growth trends and age structure Demographic indicators detailing principal causes of death and morbidity


  • Organisation & administration
  • Health expenditure
  • Hospital services
  • Outpatient care
  • Medical personnel


  • Regulatory environment
  • Distribution and trade fair information
  • Domestic production
  • Company information


  • For healthcare organisations and trade associations

For more information visit

Source: Espicom Business Intelligence Ltd

Business Wire

Last updated on: 16/03/2012

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.